NORPACE

This brand name is authorized in Turkey, United States

Active ingredients

The drug NORPACE contains one active pharmaceutical ingredient (API):

1 Disopyramide
UNII N6BOM1935W - DISOPYRAMIDE PHOSPHATE

Disopyramide is a myocardial depressant and has anti-cholinergic effects. It decreases membrane responsiveness, prolongs the effective refractory period (ERP) and slows automaticity in cells with augmented automaticity.

Read about Disopyramide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
C01BA03 Disopyramide C Cardiovascular system → C01 Cardiac therapy → C01B Antiarrhythmics, class I and III → C01BA Antiarrhythmics, class Ia
Discover more medicines within C01BA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: TR ฤฐlaรง ve Tฤฑbbi Cihaz Kurumu Identifier(s): 8699543150024, 8699543150284, 8699543150291, 8699543750057
Country: US FDA, National Drug Code Identifier(s): 0025-2732, 0025-2742, 0025-2752, 0025-2762

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.